1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Switzerland Pharmaceuticals and Healthcare Report Q1 2016

Switzerland Pharmaceuticals and Healthcare Report Q1 2016

  • December 2015
  • -
  • Business Monitor International
  • -
  • 71 pages

Includes 3 FREE quarterly updates

BMI View: Roche's restructuring efforts within its manufacturing network are indicative of deep pipelineshifts Tailored manufacturing capability will support the company's established biosimilar defence strategyas it prepares itself for erosion of key product revenues to begin in 2018 As part of an industry-wide trend,we expect to see further traditional small-molecule plants being decommissioned and investment being putinto increasing in-house biologics capabilities

Headline Expenditure Projections

- Pharmaceuticals: CHF706bn (USD771bn) in 2014 to CHF707bn (USD727bn) in 2015; +010% inlocal currency terms and -58% in US dollar terms Forecast stayed flat compared to last quarter

- Healthcare: CHF7049bn (USD7702bn) in 2014 to CHF7188bn (USD7389bn) in 2015; +20% growthin local currency terms and -41% in US dollar terms Forecast revised slightly downwards from lastquarter

Table Of Contents

Switzerland Pharmaceuticals and Healthcare Report Q1 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (2013-2019) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Switzerland 2011-2019) 13
Healthcare Market Forecast 13
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Switzerland 2011-2019) 15
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Switzerland 2011-2019) 16
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Switzerland 2011-2019) 16
Prescription Drug Market Forecast 17
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Switzerland 2011-2019) 18
Patented Drug Market Forecast 19
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Switzerland 2011-2019) 20
Generic Drug Market Forecast 21
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Switzerland 2011-2019) 22
OTC Medicine Forecast 23
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Switzerland 2011-2019) 24
Pharmaceutical Trade Forecast 25
Table: Pharmaceutical Trade Data And Forecasts (Switzerland 2013-2019) 26
Table: Pharmaceutical Trade Data And Forecasts local currency (Switzerland 2013-2019) 26
Industry Risk/Reward Index 27
Western Europe Risk/Reward Index 27
Switzerland Risk/Reward Index 33
Rewards 33
Risks 33
Regulatory Review 35
Intellectual Property Issues 35
Pricing Regime 35
Reimbursement Regime 36
Market Overview 38
Healthcare Sector 39
Table: 2013 and 2014: Health Insurance Premiums 40
Table: Healthcare Resources (Switzerland 2009-2014) 41
Table: Healthcare Personnel (Switzerland 2009-2014) 41
Table: Healthcare Activity (Switzerland 2009-2014) 42
Research And Development 42
Clinical Trials 43
Epidemiology 44
Competitive Landscape 46
Research-Based Industry 46
Table: Table: Multinational Market Activity 47
Drugmakers 48
Retail 48
Company Profile 50
Novartis 50
Roche 54
GlaxoSmithKline 58
Demographic Forecast 60
Table: Population Headline Indicators (Switzerland 1990-2025) 61
Table: Key Population Ratios (Switzerland 1990-2025) 61
Table: Urban/Rural Population and Life Expectancy (Switzerland 1990-2025) 62
Table: Population By Age Group (Switzerland 1990-2025) 62
Table: Population By Age Group % (Switzerland 1990-2025) 63
Glossary 65
Methodology 67
Pharmaceutical Expenditure Forecast Model 67
Healthcare Expenditure Forecast Model 67
Notes On Methodology 68
Risk/Reward Index Methodology 69
Index Overview 70
Table: Pharmaceutical Risk/Reward Index Indicators 70
Indicator Weightings 71

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.